Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI07251678

Publication Date:

July 2, 2025

Pages:

126

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Transdermal Drug Delivery System market size is predicted to grow from US$ 21140 million in 2025 to US$ 45900 million in 2031; it is expected to grow at a CAGR of 13.8% from 2025 to 2031.
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
Global Transdermal Drug Delivery System key players include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 45% percent.
In terms of product, Nitroglycerin is the largest segment, with a share over 25%. And in terms of application, the largest application is OTC, followed by RX.
The 鈥淭ransdermal Drug Delivery System Industry Forecast鈥� looks at past sales and reviews total world Transdermal Drug Delivery System sales in 2024, providing a comprehensive analysis by region and market sector of projected Transdermal Drug Delivery System sales for 2025 through 2031. With Transdermal Drug Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transdermal Drug Delivery System industry.
This Insight Report provides a comprehensive analysis of the global Transdermal Drug Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Transdermal Drug Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Transdermal Drug Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transdermal Drug Delivery System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transdermal Drug Delivery System.
This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Drug Delivery System market by product type, application, key players and key regions and countries.
Segmentation by Type:
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Segmentation by Application:
OTC
Rx
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transdermal Drug Delivery System Market Size (2020-2031)
2.1.2 Transdermal Drug Delivery System Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Transdermal Drug Delivery System by Country/Region (2020, 2024 & 2031)
2.2 Transdermal Drug Delivery System Segment by Type
2.2.1 Fentanyl
2.2.2 Nitroglycerin
2.2.3 Estradiol
2.2.4 Nicotine
2.2.5 Other
2.3 Transdermal Drug Delivery System Market Size by Type
2.3.1 Transdermal Drug Delivery System Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Transdermal Drug Delivery System Market Size Market Share by Type (2020-2025)
2.4 Transdermal Drug Delivery System Segment by Application
2.4.1 OTC
2.4.2 Rx
2.5 Transdermal Drug Delivery System Market Size by Application
2.5.1 Transdermal Drug Delivery System Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Transdermal Drug Delivery System Market Size Market Share by Application (2020-2025)
3 Transdermal Drug Delivery System Market Size by Player
3.1 Transdermal Drug Delivery System Market Size Market Share by Player
3.1.1 Global Transdermal Drug Delivery System Revenue by Player (2020-2025)
3.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Player (2020-2025)
3.2 Global Transdermal Drug Delivery System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Transdermal Drug Delivery System by Region
4.1 Transdermal Drug Delivery System Market Size by Region (2020-2025)
4.2 Global Transdermal Drug Delivery System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Transdermal Drug Delivery System Market Size Growth (2020-2025)
4.4 APAC Transdermal Drug Delivery System Market Size Growth (2020-2025)
4.5 Europe Transdermal Drug Delivery System Market Size Growth (2020-2025)
4.6 Middle East & Africa Transdermal Drug Delivery System Market Size Growth (2020-2025)
5 Americas
5.1 Americas Transdermal Drug Delivery System Market Size by Country (2020-2025)
5.2 Americas Transdermal Drug Delivery System Market Size by Type (2020-2025)
5.3 Americas Transdermal Drug Delivery System Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transdermal Drug Delivery System Market Size by Region (2020-2025)
6.2 APAC Transdermal Drug Delivery System Market Size by Type (2020-2025)
6.3 APAC Transdermal Drug Delivery System Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Transdermal Drug Delivery System Market Size by Country (2020-2025)
7.2 Europe Transdermal Drug Delivery System Market Size by Type (2020-2025)
7.3 Europe Transdermal Drug Delivery System Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transdermal Drug Delivery System by Region (2020-2025)
8.2 Middle East & Africa Transdermal Drug Delivery System Market Size by Type (2020-2025)
8.3 Middle East & Africa Transdermal Drug Delivery System Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Transdermal Drug Delivery System Market Forecast
10.1 Global Transdermal Drug Delivery System Forecast by Region (2026-2031)
10.1.1 Global Transdermal Drug Delivery System Forecast by Region (2026-2031)
10.1.2 Americas Transdermal Drug Delivery System Forecast
10.1.3 APAC Transdermal Drug Delivery System Forecast
10.1.4 Europe Transdermal Drug Delivery System Forecast
10.1.5 Middle East & Africa Transdermal Drug Delivery System Forecast
10.2 Americas Transdermal Drug Delivery System Forecast by Country (2026-2031)
10.2.1 United States Market Transdermal Drug Delivery System Forecast
10.2.2 Canada Market Transdermal Drug Delivery System Forecast
10.2.3 Mexico Market Transdermal Drug Delivery System Forecast
10.2.4 Brazil Market Transdermal Drug Delivery System Forecast
10.3 APAC Transdermal Drug Delivery System Forecast by Region (2026-2031)
10.3.1 China Transdermal Drug Delivery System Market Forecast
10.3.2 Japan Market Transdermal Drug Delivery System Forecast
10.3.3 Korea Market Transdermal Drug Delivery System Forecast
10.3.4 Southeast Asia Market Transdermal Drug Delivery System Forecast
10.3.5 India Market Transdermal Drug Delivery System Forecast
10.3.6 Australia Market Transdermal Drug Delivery System Forecast
10.4 Europe Transdermal Drug Delivery System Forecast by Country (2026-2031)
10.4.1 Germany Market Transdermal Drug Delivery System Forecast
10.4.2 France Market Transdermal Drug Delivery System Forecast
10.4.3 UK Market Transdermal Drug Delivery System Forecast
10.4.4 Italy Market Transdermal Drug Delivery System Forecast
10.4.5 Russia Market Transdermal Drug Delivery System Forecast
10.5 Middle East & Africa Transdermal Drug Delivery System Forecast by Region (2026-2031)
10.5.1 Egypt Market Transdermal Drug Delivery System Forecast
10.5.2 South Africa Market Transdermal Drug Delivery System Forecast
10.5.3 Israel Market Transdermal Drug Delivery System Forecast
10.5.4 Turkey Market Transdermal Drug Delivery System Forecast
10.6 Global Transdermal Drug Delivery System Forecast by Type (2026-2031)
10.7 Global Transdermal Drug Delivery System Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Transdermal Drug Delivery System Forecast
11 Key Players Analysis
11.1 Hisamitsu
11.1.1 Hisamitsu Company Information
11.1.2 Hisamitsu Transdermal Drug Delivery System Product Offered
11.1.3 Hisamitsu Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Hisamitsu Main Business Overview
11.1.5 Hisamitsu Latest Developments
11.2 Mylan
11.2.1 Mylan Company Information
11.2.2 Mylan Transdermal Drug Delivery System Product Offered
11.2.3 Mylan Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Mylan Main Business Overview
11.2.5 Mylan Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Transdermal Drug Delivery System Product Offered
11.3.3 GSK Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Transdermal Drug Delivery System Product Offered
11.4.3 Novartis Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Teve (Actavis)
11.5.1 Teve (Actavis) Company Information
11.5.2 Teve (Actavis) Transdermal Drug Delivery System Product Offered
11.5.3 Teve (Actavis) Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Teve (Actavis) Main Business Overview
11.5.5 Teve (Actavis) Latest Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Transdermal Drug Delivery System Product Offered
11.6.3 Johnson & Johnson Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Johnson & Johnson Main Business Overview
11.6.5 Johnson & Johnson Latest Developments
11.7 Lohmann
11.7.1 Lohmann Company Information
11.7.2 Lohmann Transdermal Drug Delivery System Product Offered
11.7.3 Lohmann Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Lohmann Main Business Overview
11.7.5 Lohmann Latest Developments
11.8 Teikoku Seiyaku
11.8.1 Teikoku Seiyaku Company Information
11.8.2 Teikoku Seiyaku Transdermal Drug Delivery System Product Offered
11.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Teikoku Seiyaku Main Business Overview
11.8.5 Teikoku Seiyaku Latest Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Transdermal Drug Delivery System Product Offered
11.9.3 Bayer Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Bayer Main Business Overview
11.9.5 Bayer Latest Developments
11.10 Lingrui
11.10.1 Lingrui Company Information
11.10.2 Lingrui Transdermal Drug Delivery System Product Offered
11.10.3 Lingrui Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Lingrui Main Business Overview
11.10.5 Lingrui Latest Developments
11.11 Sanofi
11.11.1 Sanofi Company Information
11.11.2 Sanofi Transdermal Drug Delivery System Product Offered
11.11.3 Sanofi Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Sanofi Main Business Overview
11.11.5 Sanofi Latest Developments
11.12 Qizheng
11.12.1 Qizheng Company Information
11.12.2 Qizheng Transdermal Drug Delivery System Product Offered
11.12.3 Qizheng Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Qizheng Main Business Overview
11.12.5 Qizheng Latest Developments
11.13 Endo
11.13.1 Endo Company Information
11.13.2 Endo Transdermal Drug Delivery System Product Offered
11.13.3 Endo Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Endo Main Business Overview
11.13.5 Endo Latest Developments
11.14 Huarun 999
11.14.1 Huarun 999 Company Information
11.14.2 Huarun 999 Transdermal Drug Delivery System Product Offered
11.14.3 Huarun 999 Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Huarun 999 Main Business Overview
11.14.5 Huarun 999 Latest Developments
11.15 Haw Par
11.15.1 Haw Par Company Information
11.15.2 Haw Par Transdermal Drug Delivery System Product Offered
11.15.3 Haw Par Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Haw Par Main Business Overview
11.15.5 Haw Par Latest Developments
11.16 Nichiban
11.16.1 Nichiban Company Information
11.16.2 Nichiban Transdermal Drug Delivery System Product Offered
11.16.3 Nichiban Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Nichiban Main Business Overview
11.16.5 Nichiban Latest Developments
11.17 Mentholatum
11.17.1 Mentholatum Company Information
11.17.2 Mentholatum Transdermal Drug Delivery System Product Offered
11.17.3 Mentholatum Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Mentholatum Main Business Overview
11.17.5 Mentholatum Latest Developments
11.18 Laboratoires Genevrier
11.18.1 Laboratoires Genevrier Company Information
11.18.2 Laboratoires Genevrier Transdermal Drug Delivery System Product Offered
11.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Laboratoires Genevrier Main Business Overview
11.18.5 Laboratoires Genevrier Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂